pCMV-dCas13-M3M14nes Citations (4)
Originally described in: Programmable m(6)A modification of cellular RNAs with a Cas13-directed methyltransferase.Wilson C, Chen PJ, Miao Z, Liu DR Nat Biotechnol. 2020 Jun 29. pii: 10.1038/s41587-020-0572-6. doi: 10.1038/s41587-020-0572-6. PubMed Journal
Articles Citing pCMV-dCas13-M3M14nes
| Articles |
|---|
Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase.
Xia Z, Tang M, Ma J, Zhang H, Gimple RC, Prager BC, Tang H, Sun C, Liu F, Lin P, Mei Y, Du R, Rich JN, Xie Q.
Nucleic Acids Res. 2021 Jul 21;49(13):7361-7374. doi: 10.1093/nar/gkab517.
PubMed
Associated Plasmids |
| N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Zou Y, Zheng S, Xie X, Ye F, Hu X, Tian Z, Yan SM, Yang L, Kong Y, Tang Y, Tian W, Xie J, Deng X, Zeng Y, Chen ZS, Tang H, Xie X. Nat Commun. 2022 May 13;13(1):2672. doi: 10.1038/s41467-022-30217-7. PubMed |
| Enhanced or reversible RNA N6-methyladenosine editing by red/far-red light induction. Tang H, Han S, Jie Y, Jiang X, Zhang Y, Peng J, Wang F, Li X, Zhou X, Jiang W, Weng X. Nucleic Acids Res. 2025 Feb 27;53(5):gkaf181. doi: 10.1093/nar/gkaf181. PubMed |
| DNA-guided CRISPR-Cas12 for cellular RNA targeting. Orosco C, Huang B, Rananaware SR, Bodin AP, Browning I, Fang A, Baugh MP, Lange IH, Elhabashy YB, Balaraju M, Lewis JG, Shah NH, Hanna MP, Flannery SJ, Meister KS, Karalkar V, Jain PK. Nat Biotechnol. 2026 May 15. doi: 10.1038/s41587-026-03129-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.